Potential involvement of DSCAML1 mutations in neurodevelopmental disorders
Potential involvement of DSCAML1 mutations in neurodevelopmental disorders
复制标题
DOI:
10.1111/gtc.12831
复制
发表时间:
2021-02-18
期刊:
影响因子:
2.1
通讯作者:
Hoshino, Mikio
中科院分区:
文献类型:
--
作者:
Ogata, Shigehiro;Hashizume, Koichi;Hoshino, Mikio
The molecular mechanisms underlying neurodevelopmental disorders (NDDs) remain unclear. We previously identified Down syndrome cell adhesion molecule like 1 (Dscaml1) as a responsible gene for Ihara epileptic rat (IER), a rat model for human NDDs with epilepsy. However, the relationship between NDDs and DSCAML1 in humans is still elusive. In this study, we screened databases of autism spectrum disorders (ASD), intellectual disability (ID)/developmental disorders (DD) and schizophrenia for genomic mutations in human DSCAML1. We then performed in silico analyses to estimate the potential damage to the mutated DSCAML1 proteins and chose three representative mutations (DSCAML1(C729R), DSCAML1(R1685*) and DSCAML1(K2108Nfs*37)), which lacked a cysteine residue in the seventh Ig domain, the intracellular region and the C-terminal PDZ-binding motif, respectively. In overexpression experiments in a cell line, DSCAML1(C729R) lost its mature N-glycosylation, whereas DSCAML1(K2108Nfs*37) was abnormally degraded via proteasome-dependent protein degradation. Furthermore, in primary hippocampal neurons, the ability of the wild-type DSCAML1 to regulate the number of synapses was lost with all mutant proteins. These results provide insight into understanding the roles of the domains in the DSCAML1 protein and further suggest that these mutations cause functional changes, albeit through different mechanisms, that likely affect the pathophysiology of NDDs.